Literature DB >> 21506246

Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socioeconomic factors.

Sammy Saab1, Hillary Bownik, Noel Ayoub, Zobair Younossi, Francisco Durazo, Steven Han, Johnny C Hong, Douglas Farmer, Ronald W Busuttil.   

Abstract

One of the current ultimate goals of orthotopic liver transplantation (OLT) is the improvement of patients' health-related quality of life (HRQOL). The purpose of this study was to look at the effects of socioeconomic and demographic differences on the short-term and long-term HRQOL outcomes of OLT recipients. Three hundred three adult OLT recipients who were seen at the University of California Los Angeles were administered the Medical Outcomes Study Short Form 36 (SF-36), the Chronic Liver Disease Questionnaire (CLDQ), and a demographic survey. A parsimonious model of 12 socioeconomic and demographic predictors was identified. Their simultaneous influence on each SF-36 and CLDQ HRQOL domain score was evaluated with multivariate linear regression and backward selection. Hepatitis C virus impaired HRQOL; this was shown in the SF-36 Vitality and Bodily Pain domains and in most CLDQ domains. Females experienced more HRQOL impairment only within the CLDQ Abdominal Symptoms domain. OLT recipients who were married had better SF-36 Role-Emotion domain scores. OLT recipients with more than 12 years of education had better SF-36 Physical Functioning scores. Employed OLT recipients had less HRQOL impairment; this was evidenced by better scores in multiple domains of the SF-36 and the CLDQ. OLT patients with health maintenance organization or preferred provider organization insurance had higher HRQOL scores within almost all SF-36 and CLDQ domains. Patients with a mix of public and private insurance had significantly higher HRQOL scores in comparison with those with only public insurance. Identifying patients at higher risk for worse HRQOL scores, less satisfaction with OLT results, and greater problems with fatigue or mental health stressors will assist transplant centers in using their medical teams to develop early interventions and multidisciplinary approaches to improve HRQOL outcomes after OLT.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21506246     DOI: 10.1002/lt.22268

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  12 in total

1.  Presumed Consent: A Potential Tool for Countries Experiencing an Organ Donation Crisis.

Authors:  Sammy Saab; Satvir S Saggi; Mizna Akbar; Gina Choi
Journal:  Dig Dis Sci       Date:  2018-12-05       Impact factor: 3.199

2.  Health-related quality of life in long-term survivors of paediatric liver transplantation.

Authors:  Stacey V Konidis; Alexander Hrycko; Scott Nightingale; Eberhard Renner; Leslie Lilly; George Therapondos; Ann Fu; Yaron Avitzur; Vicky Lee Ng
Journal:  Paediatr Child Health       Date:  2015-05       Impact factor: 2.253

Review 3.  Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research.

Authors:  Zeeshan Butt; Neehar D Parikh; Anton I Skaro; Daniela Ladner; David Cella
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

4.  PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis.

Authors:  J S Bajaj; L R Thacker; J B Wade; A J Sanyal; D M Heuman; R K Sterling; D P Gibson; R T Stravitz; P Puri; M Fuchs; V Luketic; N Noble; M White; D Bell; D A Revicki
Journal:  Aliment Pharmacol Ther       Date:  2011-09-19       Impact factor: 8.171

5.  Patient-reported outcomes in liver transplant recipients with hepatocellular carcinoma.

Authors:  Clark D Kensinger; Irene D Feurer; Heather W O'Dell; David C LaNeve; Lindsey Simmons; C Wright Pinson; Derek E Moore
Journal:  Clin Transplant       Date:  2016-07-18       Impact factor: 2.863

6.  Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients.

Authors:  Amol S Rangnekar; Caitlyn Ellerbe; Valerie Durkalski; Brendan McGuire; William M Lee; Robert J Fontana
Journal:  Liver Transpl       Date:  2013-08-18       Impact factor: 5.799

7.  A moral dilemma argument against clinical trials of incentives for kidney donation.

Authors:  G V Ramesh Prasad
Journal:  Transplant Res       Date:  2015-07-22

8.  Mode of allocation and social demographic factors correlate with impaired quality of life after liver transplantation.

Authors:  Nils Heits; Gunnar Meer; Alexander Bernsmeier; Rainer Guenther; Bjoern Malchow; Thomas Kuechler; Thomas Becker; Felix Braun
Journal:  Health Qual Life Outcomes       Date:  2015-09-30       Impact factor: 3.186

9.  The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort.

Authors:  Greta Pells; George F Mells; Marco Carbone; Julia L Newton; Andrew J Bathgate; Andrew K Burroughs; Michael A Heneghan; James M Neuberger; Darren B Day; Samantha J Ducker; Richard N Sandford; Graeme J Alexander; David E J Jones
Journal:  J Hepatol       Date:  2013-03-04       Impact factor: 25.083

10.  Factors Affecting Exercise Test Performance in Patients After Liver Transplantation.

Authors:  Katarzyna Kotarska; Ewa Wunsch; Lukasz Jodko; Joanna Raszeja-Wyszomirska; Izabela Bania; Malgorzata Lawniczak; Dimitrios Bogdanos; Zdzislawa Kornacewicz-Jach; Piotr Milkiewicz
Journal:  Hepat Mon       Date:  2016-03-21       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.